Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Sesame Care vs RxPepsDirect

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade B · #6

Sesame Care

People who specifically want FDA-approved brand-name medication (including the Wegovy pill or oral Rybelsus) from an established, verified marketplace and will budget for a two-part cost.

Visit Sesame Care
VS
Grade C · #239

RxPepsDirect

Cost-first shoppers who want the all-in per-order cost of a compounded GLP-1 with no subscription, in 28 states.

Visit RxPepsDirect

The verdict

Winner · Sesame CareGrade B vs C

Sesame Care takes it, leading the Cost-Efficiency Index 86 to 60. The widest real brand-name GLP-1 access on the board — a LegitScript- and BBB-recognized national marketplace running since 2018 that dispenses FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro and Rybelsus, not compounded copies. RxPepsDirect still earns a CCost-first shoppers who want the all-in per-order cost of a compounded GLP-1 with no subscription, in 28 states.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Sesame Care.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

76
84

Price Transparency

82
30

Nationwide Access

92
52

Formulation Options

95
66

Clinical Oversight

89
70

Contract Flexibility

84
55

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecSesame CareRxPepsDirect
Cost-Efficiency Index86/10060/100
Semaglutide / mo$149/mo (brand)$79/mo (starting dose, visit fee and shipping included, compounded)
Tirzepatide / moBrand (Zepbound)$99/mo (starting dose, visit fee and shipping included, compounded)
Semaglutide / yr (modeled)$948
Tirzepatide / yr (modeled)$1,188
CoverageNationwide28 states
Oral / sublingualYesNo
Brand-name accessYesCompounded only
Rank on the board#6#239

Sesame Care

86/100

Where the value is

  • Widest brand-name formulary we list — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and oral Rybelsus, all FDA-approved rather than compounded
  • Established national marketplace operating since 2018, with LegitScript certification and BBB recognition
  • Wegovy pill starts around $149/mo, and oral routes are available for the needle-averse

The tradeoffs

  • Two-part cost — the medication price is separate from a platform subscription, so the all-in monthly runs above the $149 headline
  • A generalist telehealth marketplace, not a dedicated GLP-1 program
Visit Sesame Care

Full Sesame Care review →

RxPepsDirect

60/100

Where the value is

  • Every component of the price is published on the site — the vial tiers, the flat visit charge and the flat overnight delivery — so the all-in monthly cost can be worked out before ordering
  • No subscription and no commitment: you pay per order, and one visit charge covers up to three peptides on the same prescription
  • Real 503A telehealth Rx — licensed NP/PA prescribers under medical director Dr. Jonathan Snipes (NPI 1821250077), dispensed by Optimal Balance Pharmacy, Texas Board #34829

The tradeoffs

  • The advertised vial price is not the monthly cost: a flat $39 medical visit charge and $15 flat FedEx shipping land on every order, and the visit charge recurs on every reorder rather than once
  • Higher doses need more than one vial a month and the site publishes no price for the dose you titrate up to, so the figure above is a floor
Visit RxPepsDirect

Full RxPepsDirect review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons